Picture of Co-Diagnostics logo

CODX Co-Diagnostics Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapMomentum Trap

Momentum

Relative Strength (%)
1m+3.32%
3m-6.4%
6m-6.87%
1yr-38.26%
Volume Change (%)
10d/3m-28.92%
Price vs... (%)
52w High-37.57%
50d MA-0.87%
200d MA-2.06%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-46.46%
Return on Equity-35.24%
Operating Margin-610.88%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Co-Diagnostics EPS forecast chart

Profile Summary

Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
April 18th, 2013
Public Since
July 12th, 2017
No. of Shareholders
154
No. of Employees
155
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
us flag iconNASDAQ Capital Market
Shares in Issue
31,259,668

CODX Share Price Performance

Upcoming Events for CODX

Q1 2024 Co-Diagnostics Inc Earnings Release

Q2 2024 Co-Diagnostics Inc Earnings Release

Co-Diagnostics Inc Annual Shareholders Meeting

Similar to CODX

Picture of Accelerate Diagnostics logo

Accelerate Diagnostics

us flag iconNASDAQ Capital Market

Picture of Acutus Medical logo

Acutus Medical

us flag iconNASDAQ Capital Market

Picture of Adapthealth logo

Adapthealth

us flag iconNASDAQ Capital Market

Picture of Aethlon Medical logo

Aethlon Medical

us flag iconNASDAQ Capital Market

Picture of Agape ATP logo

Agape ATP

us flag iconNASDAQ Capital Market

FAQ